Botulinum Toxin Type A (BOTOX
            ®
            ) for the Prophylactic Treatment of Chronic Daily Headache: A Randomized, Double‐Blind, Placebo‐Controlled Trial

Botulinum Toxin Type A for the Prophylactic Treatment of Chronic Daily Headache: A Randomized, Double-Blind, Placebo-Controlled Trial

Mayo Clinic Proceedings ◽

10.4065/80.9.1126 ◽

2005 ◽

Vol 80 (9) ◽

pp. 1126-1137 ◽

Cited By ~ 115

Author(s):

Stephen D. Silberstein ◽

Stuart R. Stark ◽

Sylvia M. Lucas ◽

Suzanne N. Christie ◽

Ronald E. Degryse ◽

...

Keyword(s):

Botulinum Toxin ◽

Chronic Daily Headache ◽

Prophylactic Treatment ◽

Controlled Trial ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Double Blind ◽

Double Blind Placebo ◽

Botulinum Toxin Type A for the Prophylaxis of Chronic Daily Headache: Subgroup Analysis of Patients Not Receiving Other Prophylactic Medications: A Randomized Double‐Blind, Placebo‐Controlled Study

Headache The Journal of Head and Face Pain ◽

10.1111/j.1526-4610.2005.05068.x ◽

2005 ◽

Vol 45 (4) ◽

pp. 315-324 ◽

Cited By ~ 146

Author(s):

David W. Dodick ◽

Alexander Mauskop ◽

Arthur H. Elkind ◽

Ronald DeGryse ◽

Mitchell F. Brin ◽

...

Keyword(s):

Botulinum Toxin ◽

Chronic Daily Headache ◽

Subgroup Analysis ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

417 RANDOMIZED, DOUBLE‐BLIND, CONTROLLED TRIAL OF BOTULINUM TOXIN TYPE‐A (PROSIGNE‐CHINESE OR BOTOX) AS COADJUVANT FOR CHRONIC DAILY HEADACHE

European Journal of Pain ◽

10.1016/s1090-3801(09)60420-1 ◽

2009 ◽

Vol 13 (S1) ◽

Cited By ~ 1

Author(s):

G.R. Lauretti ◽

C.P. Rosa ◽

I.C.P.R. Lima ◽

R. Almeida ◽

C.S. Resende

Keyword(s):

Botulinum Toxin ◽

Chronic Daily Headache ◽

Controlled Trial ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Double Blind ◽

Faculty Opinions recommendation of Does botulinum toxin type A decrease pain and lessen disability in hemiplegic survivors of stroke with shoulder pain and spasticity?: a randomized, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717962357.793466005 ◽

2012 ◽

Author(s):

Arun Bhaskar

Keyword(s):

Botulinum Toxin ◽

Shoulder Pain ◽

Controlled Trial ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Double Blind ◽

Faculty Opinions recommendation of Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725299667.793502852 ◽

2015 ◽

Author(s):

Mark Obermann ◽

Dagny Holle

Keyword(s):

Botulinum Toxin ◽

Trigeminal Neuralgia ◽

Therapeutic Effect ◽

Controlled Trial ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Double Blind ◽

Botulinum toxin type A for the treatment of glabellar lines in Chinese subjects: A multicenter, double-blind, placebo-controlled trial

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2008.11.361 ◽

2009 ◽

Vol 60 (3) ◽

pp. AB80

Keyword(s):

Botulinum Toxin ◽

Controlled Trial ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Double Blind ◽

Double Blind Placebo ◽

Chinese Subjects

Botulinum Toxin Type A (Botox) for Prophylactic Treatment of Chronic Daily Headache: A Response

Headache The Journal of Head and Face Pain ◽

10.1111/j.1526-4610.2006.00391_2.x ◽

2006 ◽

Vol 46 (3) ◽

pp. 529-530 ◽

Cited By ~ 1

Author(s):

Ninan T. Mathew ◽

David W. Dodick ◽

Keyword(s):

Botulinum Toxin ◽

Chronic Daily Headache ◽

Prophylactic Treatment ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Botulinum toxin type A in the treatment of upper extremity spasticity: A randomized, double-blind, placebo-controlled trial

Neurology ◽

10.1212/wnl.46.5.1306 ◽

1996 ◽

Vol 46 (5) ◽

pp. 1306-1306 ◽

Cited By ~ 276

Author(s):

D. M. Simpson ◽

D. N. Alexander ◽

C. F. O'Brien ◽

M. Tagliati ◽

A. S. Aswad ◽

...

Keyword(s):

Botulinum Toxin ◽

Upper Extremity ◽

Controlled Trial ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Double Blind ◽

Botulinum Toxin Type A Neuromuscular Blockade in the Treatment of Lower Extremity Spasticity in Cerebral Palsy: A Randomized, Double-Blind, Placebo-Controlled Trial,

Pediatric Physical Therapy ◽

10.1097/00001577-200107000-00007 ◽

2001 ◽

Vol 13 (2) ◽

pp. 92-94

Author(s):

Cori Pieper

Keyword(s):

Cerebral Palsy ◽

Botulinum Toxin ◽

Lower Extremity ◽

Neuromuscular Blockade ◽

Controlled Trial ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Double Blind ◽

Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial

Cephalalgia ◽

10.1177/0333102412441721 ◽

2012 ◽

Vol 32 (6) ◽

pp. 443-450 ◽

Cited By ~ 104

Author(s):

Chuan-Jie Wu ◽

Ya-Jun Lian ◽

Ya-Ke Zheng ◽

Hai-Feng Zhang ◽

Yuan Chen ◽

...

Keyword(s):

Botulinum Toxin ◽

Trigeminal Neuralgia ◽

Controlled Trial ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Double Blind ◽